Skip to content
Project Directory
  • Français
Donate Now
  • Français
  • About
    • What We Do
    • Leadership
    • Team
    • Publications
    • Careers
  • Diseases/Disorders
    • One Brain
    • ALS
    • Alzheimer’s
    • Autism
    • Brain Cancer
    • Brain Injury
    • Epilepsy
    • Mental Illness
    • Multiple Sclerosis
    • Parkinson’s
    • Stroke
    • Other
  • Research
    • Programs
    • Funding Opportunities
    • Program Partners
    • Announcements
  • Impact
  • Ways To Give
    • Your Impact
    • How You Can Help
    • Events

Funded Grants

Back to results

Prevention of Alzheimer’s Dementia in High Risk Populations: A Randomized Controlled Trial of a Combination of Cognitive Remediation and Brain Stimulation

Project Overview

This project is studying a novel intervention in 250 older persons whose major depression has been successfully treated with an antidepressant medication: a combination of cognitive remediation (CR, consisting of memory and problem solving exercises) plus transcranial Direct Current Stimulation (tDCS, a non-painful low electrical current that circulates through the brain of awake patients and stimulates their neurons). The team hypothesizes that this intervention will be more beneficial than a control (“placebo”, “sham”) condition in acutely improving cognition and then slowing down its decline over time, and in preventing the onset of MCI or AD. In addition, this project will conduct a series of laboratory tests (for example neuroimaging or genetic testing) to understand better how AD and depression are linked and how CR plus tDCS works in improving cognition in older persons with depression. If CR plus tDCS is indeed beneficial in older persons with major depression, then it can be tested in the general population or in other non-depressed populations at high risk for AD.

Principal Investigator

Benoit Mulsant , CAMH, University of Toronto

Team Members

Christopher Bowie, Queen’s University

Daniel Blumberger, Centre for Addiction and Mental Health

Tarek Rajji, Centre for Addiction and Mental Health

Aristotle Voineskos, Centre for Addiction and Mental Health

Linda Mah, Rotman Research Institute, Baycrest Centre

Mark Rapoport, Sunnybrook Research Institute

Zafiris Daskalakis, Centre for Addiction and Mental Health

Ariel Graff, Centre for Addiction and Mental Health

James Kennedy, Centre for Addiction and Mental Health

Tiffany Chow, The Rotman Research Institute, Baycrest Centre

Kevin Thorpe, University of Toronto

Alastair Flint, University Health Network

Partners and Donors

Chagnon Family

Project Ongoing

Prevention of Alzheimer’s Dementia in High Risk Populations: A Randomized Controlled Trial of a Combination of Cognitive Remediation and Brain Stimulation

  • Program Type

    Team grants

  • Area of research

    Neurodevelopment

  • Disease Area

    Alzheimer’s

  • Competition

    Chagnon Family and Brain Canada Interventions for Prevention of Alzheimer Disease and Related Disorders (ADRD) MIRI

  • Province

    Ontario

  • Start Date

    2014

  • Total Grant Amount

    $9,996,087

  • Health Canada Contribution

    $4,998,044

Contact Us

1200 McGill College Avenue
Suite 1600, Montreal, Quebec
H3B 4G7

The offices of Brain Canada Foundation are located on the traditional, ancestral territory of the Kanien'kehá:ka Peoples, a place which has long served as a site of meeting and exchange amongst nations.

+1 (514) 989-2989 info@braincanada.ca

Playing with Marbles Podcast

Join us and take a journey to the real last great frontier – the brain.

Listen

Subscribe to Brain News

Receive our monthly electronic newsletter with updates on funded projects, upcoming events and breakthroughs in brain research.

Sign up

© 2023 Brain Canada Foundation

Registration number: 89105 2094 RR0001

  • Terms and Conditions
  • Privacy Policy

Design by Field Trip & Co